Faculty profile
Richard Veldhoen
Back to facultyResearch
Read how they describe their research on their Queen's University profile.
Latest papers
Nebulised furosemide for the treatment of patients with obstructive lung disease: a systematic review protocol.
BMJ open · 2023 · first author
Latest funding
- $3,543,415
Furosemide as Supportive Therapy for Respiratory Failure secondary to Pulmonary Infection (FAST - 3).
CIHR · 2023 · Co-investigator
- $885,854
Furosemide as Supportive Therapy for Respiratory Failure secondary to Pulmonary Infection (FAST - 3).
CIHR · 2023 · Co-investigator
1 publications.
Nebulised furosemide for the treatment of patients with obstructive lung disease: a systematic review protocol.
Veldhoen R, Muscedere J
Furosemide as Supportive Therapy for Respiratory Failure secondary to Pulmonary Infection (FAST - 3).
Principal investigators: Muscedere, John; Maslove, David
Keywords: Clinical Trial; Furosemide; Respiratory Infection
Furosemide as Supportive Therapy for Respiratory Failure secondary to Pulmonary Infection (FAST - 3).
Principal investigators: Muscedere, John; Maslove, David
Keywords: Clinical Trial; Furosemide; Respiratory Infection
From public funding decisions: CIHR since 2008, NSERC since 1991 and SSHRC since 1998 with their latest competition results, the Canada Foundation for Innovation, Genome Canada, the Canadian Space Agency, Canada Research Chairs, the Fonds de recherche du Québec, Ontario research funding, Michael Smith Health Research BC, the Canadian Cancer Society, Heart & Stroke and Brain Canada.
Frequent collaborators
A short, specific email works best. This draft uses one of their recent papers; replace the parts in brackets with your own details before sending.
Profile data last refreshed on September 29, 2026 from the university directory, publication records and public research funding records.